Maksim Labkouski
Cencora (NYSE:COR) raised its 2025 adjusted EPS forecast to reflect its takeover of Retina Consultants of America, or RCA, and momentum in its U.S. healthcare solutions unit.
The healthcare company said it now expects 2025 adjusted EPS to be in